Article
Percutaneous needle fasciotomy in Dupuytren disease: A follow up of the direct outcomes considering recurrence and complications
Search Medline for
Authors
Published: | February 6, 2020 |
---|
Outline
Text
Background: The treatment of Dupuytren's contracture with needle fasciotomy is subject of controversial debates due to the high recurrence rate. The present study evaluates the results of a technique of percutaneous needle fasciotomy as a less invasive, less time-consuming and less risky alternative to conventional fasciectomy and found ways to reduce the recurrence rate significantly.
Methods: Patients and methods: In 2008 to 2018, 81 rays in 64 patients with Dupuytren's contracture were treated using the technique of the 'Percutaneous Needle Fasciotomy' (PNF). With the Classification of Tubiana 38 rays Stage I, 29 Stage II, 12 rays Stage III and 1 Stage IV were categorized. PNF was performed using without local anesthesia at several levels in the palm.
Results: Within the retrospective study 53 patients (68 rays) were reviewed. The mean age of the patients was 63.65 years. The recurrence rate was 18,86. 49 patients with 62 rays had a totally free extension in the follow up (92,4%). All patients, except one who was jobless were able to return to their job in an average of 5,5 days.
Conclusion: The technique of 'Percutaneous Needle Fasciotomy' (PNF) is reliable and relatively simple to perform, when compared to the open aponeurectomy. The rate of complications is low. The time of operation and period of recovery is shorter than for the conventional technique. The recurrence rate of this study is significantly less compared to the literature.